Insider buying last 90 days
No open-market insider purchases were filed for MORN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Sep 28 close
Morningstar confirms it will report third-quarter 2026 financial results after market close on 28 October, giving investors a fixed date to watch. The company also completed the third-quarter reconstitution of its Morningstar Market Indexes and published its 10th annual Health Savings Account Landscape Report, an industry assessment of HSA providers. Alongside these items, a filing showed Corient Private Wealth LP trimming its MORN stake by 43.6% in the period covered.
MORN closed at $191.56, down 2.3% on the day, with its close sitting between the 50-day average of $199.87 and the 200-day average of $186.75. Shorter-term momentum has weakened, with the stock down 12.5% over one month even as it holds gains of 22.9% over three months and 22.2% over six months; the one-year return stands at -17.3%. The GekkoIndex reads 62.6, placing MORN in the Accumulation zone, and the price sits 10.6% below the Gekko Fair Value of $214.36.
Over the next 20 trading days, the next earnings date of 28 October falls just outside that window, at 29 days away, following a prior quarter where actual EPS of $2.71 beat the $2.17 estimate and produced a 3% reaction. Seasonally, this calendar stretch has averaged a 4.7% move over 5 years, positive in 4 of them. No insider, Congress or unusual options activity appears in the current windows, and analyst consensus reflects 2 buy ratings with a target of $236.67.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Morningstar scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
Averages disagree
Close $191.56 sits between the 50-day ($199.87) and 200-day ($186.75) averages, or the averages disagree.
See the chart62.6, Accumulation
Reading 62.6 is in the Accumulation zone.
See the GekkoIndex10.6% below
Price is 10.6% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 29 days
Next report Oct 28, 2026, 29 days away — outside a typical 20-trading-day hold.
See earnings+4.7% on average
From this point in the calendar, the next 20 trading days averaged +4.7% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Morningstar closed at $191.56 on Sep 28, 2026, −17.3% over the past year, inside a 52-week range of $141.49 to $238.04.
Use the left and right arrow keys to read daily values.
Put MORN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Morningstar’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 62.6, in the Accumulation zone, up 3.2 points over five sessions.
Up 3.2 points over five sessions, from the Neutral zone.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 62 | +0.5% | +1.8% | ||
| Accumulation (current zone) | 231 | −0.1% | −1.4% | ||
| Neutral | 355 | −0.3% | −0.5% | ||
| Distribution | 19 | −1.2% | −0.5% | ||
| Selling | 5 | Too few readings yet | |||
Average MORN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Morningstar trades 10.6% below Gekko Fair Value of $214.36, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Morningstar shares are worth, recalculated every trading day.
$214.36
Gekko Fair Value, Sep 26, 2026
10.6% Undervalued
No open-market insider purchases were filed for Morningstar, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MORN in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in MORN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Morningstar has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold MORN.
Morningstar reports on Oct 28, 2026 (29 days away), and beat the EPS estimate in 5 of its last 7 reports.
Oct 28, 2026
29 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Feb 12, 2026 | $2.71 est $2.17 | $641.1M est $634.4M | +3.0% |
| Oct 29, 2025 | $2.55 est $2.34 | $617.4M est $634.4M | −1.7% |
| Jul 22, 2025 | $2.40 est $2.09 | $605.1M est $605.8M | −2.2% |
| Apr 22, 2025 | $2.23 est $2.06 | $581.9M est $585.8M | +3.3% |
| Feb 20, 2025 | $2.71 est $2.06 | — | −1.8% |
| Oct 23, 2024 | $2.00 est $2.01 | $569.4M est $576.6M | −3.5% |
| Jul 24, 2024 | $1.60 | $570.5M | +4.5% |
| Apr 24, 2024 | $1.49 est $1.73 | $544.0M est $2.30B | −4.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Morningstar is $236.67, +23.5% from the last close, from 2 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 2 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Jul 31 | BMO Capital | $230 | +20.1% |
| Jul 7 | UBS | $260 | +35.7% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 29, Morningstar averaged +4.7% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.3% | 3 of 5 |
| Next 10 trading days | +0.9% | 3 of 5 |
| Next 15 trading days | +0.7% | 2 of 5 |
| Next 20 trading days | +4.7% | 4 of 5 |
| Next 30 trading days | +9.6% | 4 of 5 |
For scale, MORN’s typical 20-trading-day move in either direction is about 5.6%.
Morningstar’s market cap is $7.19B, with a P/E ratio of 19.1 and revenue of $2.57B over the last twelve months.
4 headlines about Morningstar from the past week, newest first, each linking to the publisher.
Morningstar’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| SPGIS&P Global | Accumulation | 14.1% below |
| MCOMoody's | Accumulation | 10.8% below |
| MSCIMSCI | Accumulation | 11.9% below |
| FICOFair Isaac | Buying | 13.2% below |
| EFXEquifax | Buying | 12.3% below |
| TRUTransUnion | Buying | 23.4% below |
A peer links to its own page where one exists.
Morningstar’s market cap is $7.19B at the Sep 28, 2026 close of $191.56, with 37.51M shares outstanding. The shares trade on a P/E ratio of 19.1.
The consensus analyst 12-month price target for Morningstar is $236.67, +23.5% from the last close. Of the 2 firms that rated the stock in the last 90 days, 2 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Morningstar is undervalued: the Sep 28, 2026 close of $191.56 is 10.6% below Gekko Fair Value of $214.36. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Morningstar is expected to report on Oct 28, 2026 (29 days away). Analysts expect earnings of $2.97 per share on revenue of $657.3M. Morningstar beat the earnings estimate in 5 of its last 7 reports, moving 3% on average across the report.
Morningstar’s 52-week high is $238.04 and its 52-week low is $141.49; it closed at $191.56 on Sep 28, 2026, −17.3% over the past year. Over the last five years the shares peaked at $365.00 on Dec 16, 2024.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.